← Back to directory

Sang Hoon Ahn

Researcher Next ID · RN-036476

Researcher · Medicine

Yonsei University

Seoul, South Korea

Accepting doctoral researchersFunding unknown
Works count
1,156
Citation count
28,882
H-index
75
i10-index
453

Research interests

Medicine
Liver Disease Diagnosis and Treatment
Hepatitis B Virus Studies
Hepatitis C virus research
Hepatocellular Carcinoma Treatment and Prognosis
Liver Disease and Transplantation

Publications

  • Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease

    Gut · 2023 · https://doi.org/10.1136/gutjnl-2023-331003

  • Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

    Hepatology International · 2020 · 10.1007/s12072-020-10072-8

  • The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

    Hepatology International · 2020 · https://doi.org/10.1007/s12072-020-10094-2

  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

    Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.03.039

  • A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea

    Journal of Hepatology · 2019 · 10.1016/j.jhep.2019.03.028

  • 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

    Journal of Hepatology · 2018 · https://doi.org/10.1016/j.jhep.2017.11.039

  • Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B

    Journal of Hepatology · 2017 · 10.1016/j.jhep.2017.10.027

  • Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008‐2011)

    Hepatology · 2015 · https://doi.org/10.1002/hep.28376

  • Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

    Gastroenterology · 2015 · https://doi.org/10.1053/j.gastro.2015.09.043

  • Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma

    Journal of Hepatology · 2015 · 10.1016/j.jhep.2015.01.022

  • Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy

    The American Journal of Gastroenterology · 2014 · 10.1038/ajg.2014.157

  • Controlled attenuation parameter ( CAP ) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population

    Liver International · 2013 · 10.1111/liv.12282

  • Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis

    PLoS ONE · 2012 · https://doi.org/10.1371/journal.pone.0044930

  • Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

    The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70077-8

  • Prediction of microvascular invasion of hepatocellular carcinoma: Usefulness of peritumoral hypointensity seen on gadoxetate disodium‐enhanced hepatobiliary phase images

    Journal of Magnetic Resonance Imaging · 2011 · https://doi.org/10.1002/jmri.22876

  • What is the best reconstruction method after distal gastrectomy for gastric cancer?

    Surgical Endoscopy · 2011 · https://doi.org/10.1007/s00464-011-2064-8

  • HBV Genotypes: Relevance to Natural History, Pathogenesis and Treatment of Chronic Hepatitis B

    Antiviral Therapy · 2011 · 10.3851/imp1982

  • Risk Assessment of Hepatitis B Virus–Related Hepatocellular Carcinoma Development Using Liver Stiffness Measurement (FibroScan) σ

    Hepatology · 2010 · https://doi.org/10.1002/hep.24121

  • Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients

    Liver International · 2010 · https://doi.org/10.1111/j.1478-3231.2009.02192.x

  • A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis

    The American Journal of Gastroenterology · 2010 · 10.1038/ajg.2009.750

  • Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance

    Journal of Hepatology · 2004 · 10.1016/j.jhep.2004.10.026

  • Genome Replication, Virion Secretion, and e Antigen Expression of Naturally Occurring Hepatitis B Virus Core Promoter Mutants

    Journal of Virology · 2003 · 10.1128/jvi.77.12.6601-6612.2003

Current projects

    No projects listed.